Dr. Asif Ali, MD

Dr. Ali practices at Spring Branch Procedure Suites in Houston, Texas.

Dr. Ali's NPI, 1881621993, was assigned on June 26, 2006. Dr. Ali graduated from McGovern Medical School in 2002. Dr. Ali's Texas license number on file is M3449.

Dr. Ali's primary practice is Spring Branch Procedure Suites, at 8830 Long Point Rd, Houston, TX 77055 in Harris County. The practice phone is (281) 467-4047.

Dr. Ali's primary practice is Spring Branch Procedure Suites in Houston, Texas. Dr. Ali is also affiliated with Riceland Medical Center. The medical group on file is Round Table Physicians Group. Dmand AI also links Dr. Ali to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ali practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ali's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Ali has a license on file in Texas.

Dmand AI lists arterial blot clot /embolism, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension, coronary artery disease and heart blockage among the conditions Dr. Ali treats.

CMS data shows 1,201 Medicare services from Dr. Ali across 14 procedure codes in 2024, for 244 Medicare patients. Medicare paid $105,019 for them. Every service was in an office.

CMS counts 244 Medicare patients who saw Dr. Ali in 2024. The largest group is 65 to 74, with 142 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ali's median patient age at 62, with 61% women.

In 2024, Dr. Ali wrote 3,909 Medicare Part D claims for 559 patients. 86% of them were for generic drugs. CMS names the drug for 3,566 of them, across 59 drugs with 11 or more claims each, at $404,781 in total drug cost. In 2023, CMS named 4,261 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ali for performance year 2024, reported individually. Dr. Ali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ali as offering telehealth.

Dmand AI links 13 papers to Dr. Ali, published from 2022 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Artificial Intelligence. Dr. Ali has published most often in Cureus. Dr. Ali's most frequent co-authors are Khaled Abdelrahman, MD, Abdul Ali, MD and Sajid Asim Ali, MD.

CMS Open Payments shows 1,333 general payments to Dr. Ali from 76 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $156,382. It also lists 1 research payment totaling $119 in 2025.

Dmand AI lists 4 awards for Dr. Ali, most recently CMS Stage 1 EHR in 2013.

Dr. Ali graduated from McGovern Medical School in 2002. Dr. Ali is a member of ACC.

Dr. Ali is in network with 22 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.